Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity. Gao X, Jiang P, Wei X, Zhang W, et al. BMC Cancer 2023;23:359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gao X, Jiang P, Wei X, Zhang W, et al. Correction: Novel fusion protein PK5-RL-Gal-3 C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity. BMC Cancer 2023;23:359.
PMID: 37076852